Our Dermatology portfolio spans a large range of high quality, clinically-proven skin care brands for scar healing, wound healing and anti-aging. Our Dermatology brands are sold in all countries in Asia to specialist doctors in Dermatology, Plastic Surgery and Obstetrics.

Atopiclair^TM
Atopiclair^TM is a hydrolipidic skin barrier treatment that is clinically proven in randomized, double blind, controlled clinical trial programs to provide effective symptomatic relief and control of atopic dermatitis.

Atopiclair^TM is a well-tolerated, effective and corticosteroid-free option for the management of mild to moderate atopic dermatitis for infants, children and adults. Its key ingredients work in a multifactorial manner to calm the skin, repair and protect the skin barrier. It is safe for long term usage in the management of atopic dermatitis.

RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL RESULTS: Children¹(n = 142 subjects)
77% treatment success vs 0% vehicle³ (p<0.0001)
78% improvement in itch score⁴ (p<0.0001)
91% of Atopiclair patients did not require steroid rescue medication during the study (p<0.005)

Adults²(n = 218 subjects)
75% improvement in EASI score vs 13% vehicle⁵ (p<0.0001)
82% improvement in itch score⁶ (p<0.0001)
94% of Atopiclair patients did not require steroid rescue medication during the study (p<0.0001)

¹ Boguniewicz et al. J Pediatr 2008; 152(6):854-9.
² Abramovitis et al. J Drugs Dermatol 2006; 5(3):236-244.
³ Primary Endpoint: IGA (Investigator’s Global Assessment) at Day 22. 77% of Atopiclair group achieved treatment success (IGA Score 0 or 1). 0% of vehicle population achieved treatment successes.
⁴ Atopiclair group showed early and lasting improvements in itch. Mean itch score improved by Day 3, 78% by Day 43. Significantly greater improvement in itch was reported with Atopiclair vs. vehicle at all time points.
⁵ Atopiclair 75% improvement in EASI (Eczema Area and Severity Index) score in Atopiclair group vs 13% in vehicle group at the end of the study.
⁶82% improvement in itch score in the Atopiclair group at the end of the study. Itch improved early and showed continuous improvement.

Atopiclair^TM will soon be available in the Asia Pacific region.

Papulex^TM 
Papulex^TM  is a specially formulated line of products that keep acne prone skin in good condition through cleansing, treating and protecting. Well supported by clinical studies, Papulex^TM are effective with its recognized functional substances. Nicotinamide and Anti-Bacterial Adhesive substance (ABA’s) eliminate blemishes, and Zinc PCA helps to reduce sebum secretion.

Non comedogenic and non photosentitizing, Papulex^TM can be used alone or in combination with conventional acne treatments. Soon available with a Soap Free Cleansing Gel, Oil-free Cream and the Isocorrexion Hydrating Cream, Papulex^TM  offers a complete daily management for acne prone skin.

Papulex^TM  will soon be available in the Asia Pacific region.

Kinerase®
Kinerase® is a premium professional skin care range, proven in clinical trials to improve the appearance of fine lines,  wrinkles, skin texture, tone and blotchiness.  Kinerase® is suitable for all skin types, including dry,  sensitive or post-procedural skin. The active ingredient in Kinerase® is a naturally occurring biofactor, scientifically shown to delay and even reverse the effects of aging in human skin cells.

With a strong legacy as leading brand in the US professional skin care market, Kinerase® is recognized by physicians and patients in Asia as a gentle, yet effective skin care regime, for monotherapy and in combination with other anti-aging treatments, such as laser.

Kinerase® is available in Korea, Taiwan, Hong Kong, Singapore, Malaysia and received regulatory approval in China in late 2009.

Sebclair^TM
Sebclair^TM - a complete non-steroidal range of products, clinically proven for the management of seborrhoeic dermatitis and cradle cap, including the relief of its most common signs and symptoms (pruritus, erythema, burning and scaling). Its key ingredients work cohesively for the best management of skin condition.

• Piroctone Olamine – Anti-fungal action
• Acifructol/Allantoin/Bisabolol  - Keratolytic action
• Alglycera complex/ Glycyrrhetinic acid/ Bisabolol – Relief of itch and redness
• Shea Butter - Emollient & protective action
• Vitamin C,E/ Vitis Vinefera/ Telmesteine - Anti-oxidant action

Available in Cream, Shampoo and Scalp Fluid presentations to best meet the needs for different affected areas.

Sebclair^TM will soon be available in the Asia Pacific region.

Gly Derm ®
Gly Derm ® (0.1-0.125% N6-furfuryladenine) is a comprehensive skin care range with 3 distinct lines : Gly Derm® Glycolic Acid, Gly Derm® G-White and Gly Derm® Hydration.  The advanced Gly Derm® formulas are specifically developed to meet the skin care needs of Asian women.   

With a strong international brand heritage, the Gly Derm® range has been further developed based on Asian customer insights to take a leading position in the growing market for affordable, quality skin care brands for whitening and basic skin care needs.

Gly Derm® is currently sold in Taiwan and Hong Kong.